{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:10:08Z","timestamp":1759050608287,"version":"3.44.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jneuroim.2020.577432","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T21:54:22Z","timestamp":1605131662000},"page":"577432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Low serum \u0391-SYNUCLEIN and oligomer \u0391-SYNUCLEIN levels in multiple sclerosis patients"],"prefix":"10.1016","volume":"350","author":[{"given":"Nuray","family":"Bilge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recep","family":"Yevgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seda","family":"Ask\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577432_bb0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"issue":"41","key":"10.1016\/j.jneuroim.2020.577432_bb0010","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1523\/JNEUROSCI.1799-06.2006","article-title":"Alpha-synuclein expression modulates microglial activation phenotype","volume":"26","author":"Austin","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0015","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1128\/JVI.02949-15","article-title":"Alpha-synuclein expression restricts RNA viral infections in the brain","volume":"90","author":"Beatman","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2018.00036","article-title":"Silencing alpha synuclein in mature nigral neurons results in rapid neuroinflammation and subsequent toxicity","volume":"11","author":"Benskey","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(00)01153-8","article-title":"Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson\u2019s disease and normal subjects","volume":"287","author":"Borghi","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1191\/135248506ms1263oa","article-title":"Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis","volume":"12","author":"Brettschneider","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0040","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0045","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1096\/fj.04-3437fje","article-title":"Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway","volume":"19","author":"Cappai","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0050","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.10326","article-title":"Thalamic neurodegeneration in multiple sclerosis","volume":"52","author":"Cifelli","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-2236(97)01213-7","article-title":"The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease","volume":"21","author":"Clayton","year":"1998","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0060","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1471-4159.2011.07199.x","article-title":"Regulation of a-synuclein expression in cultured cortical neurons","volume":"117","author":"Clough","year":"2011","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577432_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055375","article-title":"Triggering of Inflammasome by aggregated a\u2013Synuclein, an inflammatory response in Synucleinopathies","volume":"8","author":"Codolo","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577432_bb0070","doi-asserted-by":"crossref","first-page":"e1265","DOI":"10.1038\/cddis.2014.211","article-title":"Role of alpha-synuclein in autophagy modulation of primary human T lymphocytes","volume":"5","author":"Colasanti","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0345","series-title":"Natural history of multiple sclerosis. Presse M\u00e9dicale (Paris, France\u202f: 1983)","first-page":"606","volume":"129","author":"Vukusic","year":"2006"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0075","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of alpha-synuclein","volume":"149","author":"Cremades","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0080","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","article-title":"Different species of alpha-synuclein oligomers induce calcium influx and seeding","volume":"27","author":"Danzer","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0090","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","article-title":"Alpha-synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, including human plasma","volume":"17","author":"El-Agnaf","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of \u03b1-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577432_bb0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/CCLM.2011.077","article-title":"Alpha-synuclein in Parkinson disease and other neurodegenerative disorders","volume":"49","author":"Eller","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.dib.2016.11.089","article-title":"Dataset of total, oligomeric alpha-synuclein and hemoglobin levels in plasma in Parkinson\u2019s disease","volume":"10","author":"Emelyanov","year":"2016","journal-title":"Data Brief"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-016-0694-4","article-title":"\u03b1-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses","volume":"13","author":"Ettle","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0115","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ar050073t","article-title":"The aggregation and fibrillation of alpha-synuclein","volume":"39","author":"Fink","year":"2006","journal-title":"Acc. Chem. Res."},{"issue":"28","key":"10.1016\/j.jneuroim.2020.577432_bb0120","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.5314-13.2014","article-title":"Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson\u2019s disease-like models","volume":"34","author":"Games","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0071634","article-title":"Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease","volume":"8","author":"Gardai","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577432_bb0130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4049\/jimmunol.171.1.368","article-title":"Vulnerability of human neurons to T cell-mediated cytotoxicity","volume":"171","author":"Giuliani","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0135","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1021\/bi0341152","article-title":"Nuclear localization of alpha-synuclein and its interaction with histones","volume":"42","author":"Goers","year":"2003","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577432_bb0140","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","article-title":"Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients","volume":"128","author":"Grozdanov","year":"2014","journal-title":"Acta Neuropathol."},{"issue":"Pt 3","key":"10.1016\/j.jneuroim.2020.577432_bb0145","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and a-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0150","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jnnp.2009.197483","article-title":"Differential levels of a-synuclein, b-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"81","author":"Kasuga","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0155","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0160","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"N. et al. direct observation of the interconversion of normal and toxic forms of alpha-synuclein","volume":"149","author":"Kruger","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awf235","article-title":"Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time","volume":"125","author":"Kuhlmann","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0175","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000479653","article-title":"P. Brundin, Alpha-synuclein to the rescue: immune cell recruitment by alpha-synuclein during gastrointestinal infection","volume":"9","author":"Labrie","year":"2017","journal-title":"J. Innate Immun."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577432_bb0180","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0185","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0195","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577432_bb0200","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41467-020-15626-w","article-title":"\u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease","volume":"11","author":"Lindestam Arlehamn","year":"2020","journal-title":"Nat Commun."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000327098.86861.d4","article-title":"A multidisciplinary study of patients with early-onset PD with and without parkin mutations","volume":"72","author":"Lohmann","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0210","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nrd2358","article-title":"Novel therapeutic strategies for multiple sclerosis-a multifaceted adversary","volume":"7","author":"Lopez-Diego","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Pt 2","key":"10.1016\/j.jneuroim.2020.577432_bb0215","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/brain\/123.2.308","article-title":"Axonal changes in chronic demyelinated cervical spinal cord plaques","volume":"123","author":"Lovas","year":"2000","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0220","first-page":"179","article-title":"Association of >-Synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions","volume":"68","author":"Lu","year":"2009"},{"issue":"Pt 7","key":"10.1016\/j.jneuroim.2020.577432_bb0225","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ane.12247","article-title":"Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review","volume":"130","author":"Malek","year":"2014","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.jneuroim.2020.577432_bb0235","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0002-9440(10)61755-5","article-title":"Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes","volume":"159","author":"Medana","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2018.11.003","article-title":"Low levels of alpha-synuclein in peripheral tissues are related to clinical relapse in relapsing-remitting multiple sclerosis: a pilot cross-sectional study","volume":"396","author":"Mej\u00eda","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0245","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF a-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2020.577432_bb0250","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","article-title":"Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0255","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.mcn.2006.01.007","article-title":"Upregulation of alpha-synuclein in neurons and glia in inflammatory demyelinating disease","volume":"31","author":"Papadopoulos","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0260","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.1123","article-title":"Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions","volume":"50","author":"Peterson","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0265","doi-asserted-by":"crossref","first-page":"21742","DOI":"10.1074\/jbc.M113.451815","article-title":"Alpha- Synuclein oligomers impair neuronal microtubule-kinesin interplay","volume":"288","author":"Prots","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577432_bb0270","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.parkreldis.2008.08.002","article-title":"Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus?","volume":"15","author":"Puschmann","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0275","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/jnc.13163","article-title":"Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis","volume":"134","author":"Antonelou","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3233\/JAD-2010-100186","article-title":"CSF a-synuclein does not discriminate dementia with Lewy bodies from Alzheimer\u2019s disease","volume":"22","author":"Reesink","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0285","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/mdc3.12494","article-title":"The presence of alpha-synuclein in skin from melanoma and patients with Parkinson's disease","volume":"4","author":"Rodriguez-Leyva","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0290","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/540S2a","article-title":"Biology: a degenerative affliction","volume":"540","author":"Schmidt","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577432_bb0295","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.imbio.2015.10.002","article-title":"A critical role for alpha-synuclein in development and function of T lymphocytes","volume":"221","author":"Shameli","year":"2016","journal-title":"Immunobiology."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577432_bb0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12017-017-8475-5","article-title":"Serum Mortalin correlated with \u03b1-Synuclein as serum markers in Parkinson\u2019s disease: a pilot study","volume":"20","author":"Singh","year":"2018","journal-title":"Neuromolecular Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2020.577432_bb0305","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12974-016-0632-5","article-title":"Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model","volume":"13","author":"Sommer","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0310","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-immunol-032713-120227","article-title":"Immunology of relapse and remission in multiple sclerosis","volume":"32","author":"Steinman","year":"2014","journal-title":"Annu Rev Immunol"},{"issue":"3A","key":"10.1016\/j.jneuroim.2020.577432_bb0315","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1590\/S0004-282X2009000400017","article-title":"Psychiatric disorders in multiple sclerosis patients","volume":"67","author":"FazzitoI","year":"2009","journal-title":"Arc Neuro-Psiquiatr"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0320","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","article-title":"Decreased a-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson\u2019s disease","volume":"349","author":"Tokuda","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0325","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2020.577432_bb0330","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00019052-199906000-00008","article-title":"Axonal pathology in multiple sclerosis: relationship to neurologic disability","volume":"12","author":"Trapp","year":"1999","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0335","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","article-title":"Pathological roles of a-synuclein in neurological disorders","volume":"10","author":"Vekrellis","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0340","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jnc.13249","article-title":"Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies","volume":"139","author":"Villar-Piqu\u00e9","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0350","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1471-4159.2012.07749.x","article-title":"Cerebrospinal fluid \u03b1-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase","volume":"122","author":"Wang","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2020.577432_bb0355","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jneuroim.2020.577432_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"Alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.jneuroim.2020.577432_bb0365","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.imbio.2014.07.014","article-title":"Late stages of hematopoiesis and B cell lymphopoiesis are regulated by \u03b1-synuclein, a key player in Parkinson\u2019s disease","volume":"219","author":"Xiao","year":"2014","journal-title":"Immunobiology."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820306937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820306937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:37:50Z","timestamp":1759048670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572820306937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":72,"alternative-id":["S0165572820306937"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577432","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low serum \u0391-SYNUCLEIN and oligomer \u0391-SYNUCLEIN levels in multiple sclerosis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577432","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577432"}}